BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25721756)

  • 41. Rapid detection of DNMT3A R882 codon mutations allows early identification of poor risk patients with acute myeloid leukemia.
    Brewin JN; Horne GA; Bisling KE; Stewart HJ; Chevassut TJ
    Leuk Lymphoma; 2013 Jun; 54(6):1336-9. PubMed ID: 23035745
    [No Abstract]   [Full Text] [Related]  

  • 42. Two novel methods for rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia.
    Mancini M; Hasan SK; Ottone T; Lavorgna S; Ciardi C; Angelini DF; Agostini F; Venditti A; Lo-Coco F
    J Mol Diagn; 2015 Mar; 17(2):179-84. PubMed ID: 25554589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic relevance of DNMT3A R882 mutations in AML patients undergoing non-myeloablative conditioning hematopoietic stem cell transplantation.
    Schmalbrock LK; Bonifacio L; Bill M; Jentzsch M; Schubert K; Grimm J; Cross M; Lange T; Vucinic V; Pönisch W; Behre G; Franke GN; Niederwieser D; Schwind S
    Bone Marrow Transplant; 2018 May; 53(5):640-643. PubMed ID: 29335621
    [No Abstract]   [Full Text] [Related]  

  • 44. Prognostic significance of DNMT3A mutations in patients with acute myeloid leukemia.
    Ibrahem L; Mahfouz R; Elhelw L; Abdsalam EM; Soliman R
    Blood Cells Mol Dis; 2015 Jan; 54(1):84-9. PubMed ID: 25172541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between DNMT3A mutations and prognosis of adults with de novo acute myeloid leukemia: a systematic review and meta-analysis.
    Tie R; Zhang T; Fu H; Wang L; Wang Y; He Y; Wang B; Zhu N; Fu S; Lai X; Shi J; Huang H
    PLoS One; 2014; 9(6):e93353. PubMed ID: 24936645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.
    Russler-Germain DA; Spencer DH; Young MA; Lamprecht TL; Miller CA; Fulton R; Meyer MR; Erdmann-Gilmore P; Townsend RR; Wilson RK; Ley TJ
    Cancer Cell; 2014 Apr; 25(4):442-54. PubMed ID: 24656771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Functional Analysis of DNMT3A DNA Methyltransferase Mutations Reported in Patients with Acute Myeloid Leukemia.
    Khrabrova DA; Loiko AG; Tolkacheva AA; Cherepanova NA; Zvereva MI; Kirsanova OV; Gromova ES
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31861499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-guided functional suppression of AML-associated DNMT3A hotspot mutations.
    Lu J; Guo Y; Yin J; Chen J; Wang Y; Wang GG; Song J
    Nat Commun; 2024 Apr; 15(1):3111. PubMed ID: 38600075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia.
    Zhang YY; Yao DM; Zhu XW; Zhou JD; Ma JC; Yang J; Wen XM; Guo H; Lin J; Qian J
    Leuk Res; 2015 Oct; 39(10):1041-7. PubMed ID: 26242829
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epimutations mimic genomic mutations of DNMT3A in acute myeloid leukemia.
    Jost E; Lin Q; Weidner CI; Wilop S; Hoffmann M; Walenda T; Schemionek M; Herrmann O; Zenke M; Brümmendorf TH; Koschmieder S; Wagner W
    Leukemia; 2014 Jun; 28(6):1227-34. PubMed ID: 24280869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNMT3A mutations at R882 hotspot are only found in major clones of acute myeloid leukemia.
    Bisling KE; Brewin JN; McGovern AP; Horne GA; Rider T; Stewart HJ; Ramsahoye BH; Chevassut TJ
    Leuk Lymphoma; 2014 Mar; 55(3):711-4. PubMed ID: 23741974
    [No Abstract]   [Full Text] [Related]  

  • 52. Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.
    Yuan XQ; Zhang DY; Yan H; Yang YL; Zhu KW; Chen YH; Li X; Yin JY; Li XL; Zeng H; Chen XP
    Oncotarget; 2016 Sep; 7(37):60555-60574. PubMed ID: 27528035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA methylation and hydroxymethylation patterns in acute myeloid leukemia patients with mutations in DNMT3A and IDH1/2 and their combinations.
    Šestáková Š; Krejčík Z; Folta A; Cerovská E; Šálek C; Merkerová MD; Pecherková P; Ráčil Z; Mayer J; Cetkovský P; Remešová H
    Cancer Biomark; 2019; 25(1):43-51. PubMed ID: 30988238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistence of DNMT3A mutations at long-term remission in adult patients with AML.
    Pløen GG; Nederby L; Guldberg P; Hansen M; Ebbesen LH; Jensen UB; Hokland P; Aggerholm A
    Br J Haematol; 2014 Nov; 167(4):478-86. PubMed ID: 25371149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia.
    Rau RE; Rodriguez BA; Luo M; Jeong M; Rosen A; Rogers JH; Campbell CT; Daigle SR; Deng L; Song Y; Sweet S; Chevassut T; Andreeff M; Kornblau SM; Li W; Goodell MA
    Blood; 2016 Aug; 128(7):971-81. PubMed ID: 27335278
    [TBL] [Abstract][Full Text] [Related]  

  • 56. AML-Associated Mutations in DNA Methyltransferase DNMT3A.
    Khrabrova DA; Yakubovskaya MG; Gromova ES
    Biochemistry (Mosc); 2021 Mar; 86(3):307-318. PubMed ID: 33838631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acute myeloid leukemia-associated DNMT3A p.Arg882His mutation in a patient with Tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation.
    Kosaki R; Terashima H; Kubota M; Kosaki K
    Am J Med Genet A; 2017 Jan; 173(1):250-253. PubMed ID: 27991732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B.
    Itonaga H; Imanishi D; Wong YF; Sato S; Ando K; Sawayama Y; Sasaki D; Tsuruda K; Hasegawa H; Imaizumi Y; Taguchi J; Tsushima H; Yoshida S; Fukushima T; Hata T; Moriuchi Y; Yanagihara K; Miyazaki Y
    Leukemia; 2014 Jul; 28(7):1459-66. PubMed ID: 24457336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNMT3A mutation leads to leukemic extramedullary infiltration mediated by TWIST1.
    Xu J; Zhang W; Yan XJ; Lin XQ; Li W; Mi JQ; Li JM; Zhu J; Chen Z; Chen SJ
    J Hematol Oncol; 2016 Oct; 9(1):106. PubMed ID: 27724883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.